Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (201-210 of 446) with videos related to

Pageof 45
Sort By:
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Blood Cancer Journal|April 15, 2020
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosisSurbhi Sidana, Paolo Milani, Moritz Binder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Leukemia|October 26, 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsS K Kumar, A Dispenzieri, M Q Lacy, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell TransplantationAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Blood|August 25, 2005
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myelomaS Vincent Rajkumar, Suzanne R Hayman, Martha Q Lacy, et al.
Pageof 45

Showing results (201-210 of 446) with videos related to

Sort By:
Pageof 45
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
Blood Cancer Journal|April 15, 2020
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosisSurbhi Sidana, Paolo Milani, Moritz Binder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Leukemia|October 26, 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsS K Kumar, A Dispenzieri, M Q Lacy, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell TransplantationAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Blood|August 25, 2005
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myelomaS Vincent Rajkumar, Suzanne R Hayman, Martha Q Lacy, et al.
Pageof 45